• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PAA
Click for more information
6.98% 23.0¢

PHARMAUST LIMITED - Charts / Financials

Market Cap $82.69M  ! watchlist Created with Sketch. Add to my watchlist

PharmAust Limited is a clinical-stage biotechnology company developing therapeutics for... PharmAust Limited is a clinical-stage biotechnology company developing therapeutics for human and animal health applications. The Company’s segments include Corporate and Research. The Company is focused on repurposing monepantel (MPL) for human neurodegenerative diseases. The Company's lead candidate, Monepantel (MPL), is a potent and safe inhibitor of the mTOR pathway, that plays a central role in cell growth and proliferation of cancer cells and in degenerating neurons. The Company is also developing MPL as a treatment for motor neuron disease (MND/ALS), a rare, incurable disease. It is focused on starting Phase II/III clinical study of MPL. It has also completed a Phase II oncology clinical study of MPL in humans and pilot studies in canine cancer. It is also preparing a pivotal monepantel field trial in dogs with B-Cell Lymphoma to enable product registration in the United States.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 00.00am 12/11/2024 (20 minute delay) ?
Day
Open 21.5¢   Day High 23.0¢   Day Low 21.5¢
Daily Volume 2128951
Bids   Sellers
Number Price Volume   Number Price Volume
4 22.5¢ 93524   2 23.0¢ 71004

Directors & Senior Management

Dr. Michael Thurn Chief Executive Officer, Managing Director, Director
Mr. John Clark Chief Operating Officer
Dr. Nicky Wallis Chief Scientific Officer
Ms. Fiona Milner General Manager - Epichem Pty Ltd
Mr. Stefan Ross Company Secretary
Mr. Sergio Duchini Non-Executive Chairman of the Board
Mr. Marcus Paul Hughes Non-Executive Director
Dr. Kathryn Macfarlane Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
23.0¢ 		Change
0.015(6.98%) 		Mkt cap ! $82.69M
Open High Low Value Volume
21.5¢ 23.0¢ 21.5¢ $475.3K 2.128M

Buyers (Bids)

No. Vol. Price($)
4 93524 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
23.0¢ 71004 2
View Market Depth
Last trade - 16.10pm 14/10/2024 (20 minute delay) ?

Top Stories

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
US election outcomes: Key economic and market takeaways This week on Money @ Investing, Mitch Olarenshaw and I break down the recent U.S. presidential election, focusing on its effects on the stock market and the broader economic outlook. Here’s what we covered:1. Election results and policy insightsThe Republican Party&CloseCurlyQuote...
Power gets set for 1000-metre maiden drilling program in Brazil Power Minerals Ltd is planning a maiden drilling program to 1000 metres to test targets at its Nióbio project in Brazil
Quit before you're fired: Russia bans uranium exports to USA, duplicating extant US ban Russia's ban of uranium exports to the USA came days before Biden allowed Ukraine use long-range missiles.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.